NHS Branded Medicines Tranche Framework for London and South of England

NHS EnglandcontractContracts Finder ↗Ref CF-2545400D0O000000rwimUAASME suitablecomplete

Estimated value

£381.0m

Awarded value

£381.0m

Awarded 21 Jul 2024

Suppliers

1

Lots

1

1 awarded

Published

20 Aug 2024

Deadline 05 Apr 2024

Awarded suppliers· 1 supplier

Awarded 21 Jul 2024 · Contract period 31 Aug 2024 — 30 Aug 2026

Award value

£381.0m

1

SP

Sun Pharma UK Ltd,Biogen,Merck Sharpe & Dohme (UK) Limited,Celltrion Healthcare United Kingdom Limited,AstraZeneca,Janssen-Cilag Ltd,Organon Pharmaceuticals UK Ltd,Thornton and Ross Ltd,GlaxoSmithKline UK Limited,Takeda UK Ltd,Pfizer Ltd,Novartis Pharmaceuticals UK Ltd,Zentiva Pharma UK Ltd,Roche Products Ltd,Eli Lilly & Company Ltd,Aventis Pharma ltd t/a Sanofi,Accord-UK Ltd,Orifarm UK,Galapagos Biotech Ltd,Manx Healthcare Ltd,Chugai Pharma UK Ltd,Napp Pharmaceuticals Ltd,Dr.Reddy's Laboratories (UK) Limited,LEO Pharma,Gedeon Richter UK Ltd,BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Sobi (Swedish Orphan Biovitrum Ltd),Teva UK Limited,UCB Pharma Ltd (primary)